Bionime Corporation (TPE:4737)
Taiwan · Delayed Price · Currency is TWD 58.80
-0.20 (-0.34%)
Sep 8, 2026, 1:30 PM CST
Bionime Market Cap
Bionime has a market cap or net worth of 4.56 billion as of September 8, 2026. Its market cap has decreased by -4.62% in one year.
Market Cap
4.56B
Enterprise Value
6.84B
Revenue
1.72B
Ranking
n/a
PE Ratio
n/a
Stock Price
58.80
ChartMarket Cap Chart
Since September 3, 2009, Bionime's market cap has increased from 2.06B to 4.56B, an increase of 121.10%. That is a compound annual growth rate of 4.77%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 8, 2026 | 4.56B | 13.96% |
| Dec 31, 2025 | 4.00B | 1.37% |
| Dec 31, 2024 | 3.95B | -13.19% |
| Dec 29, 2023 | 4.55B | -2.90% |
| Dec 30, 2022 | 4.69B | 2.61% |
| Dec 30, 2021 | 4.57B | 12.53% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Bioteque | 7.83B |
| Medeon Biodesign | 7.08B |
| Pacific Hospital Supply | 5.66B |
| Formosa Optical Technology | 5.52B |
| St.Shine Optical | 5.02B |
| ICARES Medicus | 3.63B |
| SciVision Biotech | 3.43B |
| Maxigen Biotech | 3.41B |